| 06 Apr, 08:51 am | — | … | Aurobindo Pharma Ltd - 524804 - Intimation Of Record Date For Buyback | bse |
| 06 Apr, 08:35 am | — | … | Aurobindo Pharma Ltd - 524804 - Transfer Of Company''s Domestic Branded Pharmaceutical Formulation Business To Auropharm Limited, A Wholly Owned Subsidiary Of The Company., | bse |
| 06 Apr, 08:31 am | — | … | Aurobindo Pharma Limited has informed regarding Disclosure of material issue | nse |
| 06 Apr, 08:29 am | — | … | Aurobindo Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on April 06, 2026. | nse |
| 06 Apr, 08:24 am | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors - Buyback Of Shares | bse |
| 31 Mar, 08:37 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for To Consider, Inter Alia, A Proposal For Buyback Of The Fully Paid-Up Equity Shares Of The Company | bse |
| 30 Mar, 05:44 pm | — | … | Update on solar power purchase agreement and acquisition upto 26% stake in Swarnaakshu Solar Power Private Limited. | nse |
| 25 Mar, 04:56 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Entry into Marketing and Distribution Agreement for Biosimilars in EU Territories by CuraTeQ Biologics Private Limited. | nse |
| 20 Mar, 10:00 am | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 20 Mar, 09:57 am | — | … | Aurobindo Pharma Ltd - 524804 - Classification Of Unit-V Of Apitoria Pharma Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA | bse |
| 17 Mar, 04:31 pm | — | … | Aurobindo Pharma Ltd - 524804 - Classification Of Unit-II Of Eugia Pharma Specialities Limited, A Wholly Owned Subsidiary Of The Company As OAI By The US FDA | bse |
| 17 Mar, 04:26 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 13 Mar, 12:54 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 13 Mar, 12:50 pm | — | … | Aurobindo Pharma Ltd - 524804 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 12 Mar, 09:49 am | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 12 Mar, 09:44 am | — | … | Aurobindo Pharma Ltd - 524804 - Classification Of Unit-IV Of APL Healthcare Limited, A Wholly Owned Subsidiary Of The Company As VAI By The US FDA - Reg., | bse |
| 04 Mar, 12:13 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Eugia Pharma announces launch of Pomalidomide Capsules in the US". | nse |
| 04 Mar, 12:08 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 02 Mar, 09:52 am | — | … | The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma's P Sarath Chandra Reddy acquitted in Delhi Liquor Scam case.. The response from the Company is attached. | nse |
| 27 Feb, 07:16 pm | — | … | The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma's P Sarath Chandra Reddy acquitted in Delhi Liquor Scam case.. The response from the Company is awaited. | nse |
| 27 Feb, 04:09 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd | nse |
| 26 Feb, 11:51 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 26 Feb, 11:47 am | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Submission of press release that Eugia Pharma receives USFDA Approval for Everolimus Tablets.". | nse |
| 24 Feb, 04:33 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 24 Feb, 04:28 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Incorporation of new wholly owned subsidiary in India | nse |
| 19 Feb, 03:17 pm | — | … | Aurobindo Pharma Ltd - 524804 - Intimation Of Orders Passed By The Goods & Services Tax Department | bse |
| 19 Feb, 03:13 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about orders passed by under Central Goods and Services Tax Act | nse |
| 18 Feb, 01:38 pm | — | … | Aurobindo Pharma Ltd - 524804 - Clarification On News Item Appearing In Https://Www.Ndtvprofit.Com/" | bse |
| 18 Feb, 01:33 pm | — | … | The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma Shares Fall After USFDA Flags Quality Concerns At Telangana Plant.. The response from the Company is attached. | nse |
| 18 Feb, 11:39 am | — | … | The Exchange has sought clarification from Aurobindo Pharma Limited with respect to recent news item captioned Aurobindo Pharma Shares Fall After USFDA Flags Quality Concerns At Telangana Plant.. The response from the Company is awaited. | nse |
| 16 Feb, 11:24 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Transcript | nse |
| 16 Feb, 11:17 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 13 Feb, 06:34 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEY (difamilast 1%) Ointment for the Treatment of Mild-to-Moderate Atopic Dermatitis". | nse |
| 13 Feb, 06:34 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Feb, 10:07 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 10 Feb, 10:04 pm | — | … | Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit-VII Of Aurobindo Pharma Limited, Jedcherla | bse |
| 10 Feb, 07:02 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 10 Feb, 06:58 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 09 Feb, 08:05 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Restructuring | bse |
| 09 Feb, 08:04 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Amalgamation of two wholly owned subsidiaries of the Company. | nse |
| 09 Feb, 08:00 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 09 Feb, 08:00 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Acquisition of 26% stake in Garuda Renewables Private Limited | nse |
| 09 Feb, 07:56 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Change in Directorate | bse |
| 09 Feb, 07:55 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding Change in Director(s) of the company. | nse |
| 09 Feb, 07:50 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 09 Feb, 07:48 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 09 Feb, 07:47 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31, 2025.". | nse |
| 09 Feb, 07:41 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 09 Feb, 07:36 pm | — | … | Aurobindo Pharma Ltd - 524804 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025 | bse |
| 09 Feb, 07:33 pm | — | … | Aurobindo Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. | nse |